Adagio Medical
New York, New York, United States · Biotechnology, Healthcare, Health Care
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Cryoablation (ULTC) technology. ULTC is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The Com
Key facts
- Headquarters
- New York, New York, United States
- Employees
- 47
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Private
- Website
- adagiomedical.com
- Company page
Recent activity at Adagio Medical
- : Adagio Medical has closed a $19 million private placement to advance its Ultra-Low Temperature Cryoablation technology for ventricular tachycardia, led by healthcare-focused institutional investors.
- : Adagio Medical and ARYA IV Partner to Create a Publicly Traded Company Focused on Innovative Technologies for Treatment of Cardiac Arrhythmias
- : ADAGIO MEDICAL
- : ADAGIO MEDICAL, INC.
- : ADAGIO MEDICAL, INC.
- : ADAGIO MEDICAL, INC.
- : ADAGIO MEDICAL, INC.
Adagio Medical funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2025 | Post-IPO Equity | $19.0M |
| Nov 2022 | Venture | $9.5M |
| Nov 2020 | Venture | $42.5M |
| Apr 2019 | Venture | $7.0M |
| Oct 2018 | Venture | $16.0M |
Leadership
- Michael Zhao, Director
- James Cox, Director
- Olav Bergheim, Executive Officer, Director
- Michael Zhao, Director
- James Cox, Director
- Olav Bergheim, Executive Officer, Director
- Michael Zhao, Director
- James Cox, Director
- Olav Bergheim, Executive Officer, Director
- Deborah Berland Kaster, Chief Financial Officer
- Todd Usen, President
- Andrew Wade, Executive Officer
Verified email and direct lines for Adagio Medical’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Adagio Medical files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Adagio Medical in the news
- Adagio Medical Holdings, Inc. (ADGM) stock price, news, quote and history - Yahoo Finance Singapore (Aug 01, 2024)
- Adagio Medical Announces Initiation and First Patient Enrollment in PARALELL Trial To Investigate Safety and Performance of CryoPulse™ Catheter System for Pulsed Field Ablation and Pulsed Field Cryoablation of Persistent Atrial Fibrillation - BioSpace (Oct 24, 2022)
- Adagio Medical Announces Strategic Review Process to Maximize Shareholder Value - Business Wire (Sep 23, 2026)
- Pulsed Field Cryoablation Eliminated AF in 85% After Single Ablation Procedure - www.dicardiology.com (Aug 09, 2021)
- Adagio Medical Holdings, Inc. (ADGM) Stock Price, News, Quote & History - Yahoo! Finance Canada (Aug 01, 2024)
- Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System - Business Wire (Aug 03, 2026)
- Adagio Medical Raises $42.5 Million In Series E Financing - PR Newswire UK (Nov 13, 2020)
- Adagio Medical Reports Second Quarter 2026 Results - Business Wire (Aug 11, 2026)
Companies similar to Adagio Medical
- BrainScope · Biotechnology, Healthcare, Health Care, Medical, Medical Device
- Check-Cap Ltd · Biotechnology, Healthcare, Health Care, Medical, Medical Device
- Tenon Medical · Biotechnology, Healthcare, Health Care, Medical, Medical Device
- Zenflow · Biotechnology, Healthcare, Health Care, Medical, Medical Device
- Avenda Health, Inc. · Biotechnology, Healthcare, Health Care, Medical, Medical Device
About Adagio Medical: questions and answers
What does Adagio Medical do?
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Cryoablation (ULTC) technology. ULTC is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The Com
Where is Adagio Medical headquartered?
Adagio Medical is headquartered in New York, New York, United States.
How many employees does Adagio Medical have?
Adagio Medical has about 47 employees.
Has Adagio Medical raised funding?
Yes. Fundz has recorded 5 funding events for Adagio Medical. The most recent, Post-IPO Equity of $19.0M, was in Oct 2025.
Who leads Adagio Medical?
Todd Usen is a President at Adagio Medical.
What is the latest news on Adagio Medical?
On Oct 20, 2025, Adagio Medical has closed a $19 million private placement to advance its Ultra-Low Temperature Cryoablation technology for ventricular tachycardia, led by healthcare-focused institutional investors.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy